Suppression of mesangial proliferative glomerulonephritis development in rats by inhibitors of cAMP phosphodiesterase isozymes types III and IV
about
Nifedipine suppresses neointimal thickening by its inhibitory effect on vascular smooth muscle cell growth via a MEK-ERK pathway coupling with Pyk2Arginine vasopressin stimulates mesangial cell proliferation by activating the epidermal growth factor receptorStimulation of soluble guanylyl cyclase inhibits mesangial cell proliferation and matrix accumulation in experimental glomerulonephritis.MAPK signaling and the kidney.Cyclic nucleotide signalling in kidney fibrosis.Direct in vivo inhibition of the nuclear cell cycle cascade in experimental mesangial proliferative glomerulonephritis with Roscovitine, a novel cyclin-dependent kinase antagonist.Profiling of functional phosphodiesterase in mesangial cells using a CRE-SEAP-based reporting system.Alternative therapies for vasculitis and proliferative nephritides: the role of cyclic AMP elevating agents.Sildenafil, a phosphodiesterase type 5 inhibitor, attenuates diabetic nephropathy in non-insulin-dependent Otsuka Long-Evans Tokushima Fatty rats.Ca(2+)/calmodulin-dependent and cAMP-dependent kinases in induction of c-fos in human mesangial cells.c-Jun NH2-terminal kinase mediation of angiotensin II-induced proliferation of human mesangial cells.Effects of pentoxifylline on amikacin-induced nephrotoxicity in rats.Therapeutic efficacy of pentoxifylline on proteinuria and renal progression: an update.Therapeutics in renal disease: the road ahead for antiproliferative targets.
P2860
Q28578027-6A16A4A8-3ED2-4369-9CD6-7DEB3A04D1E9Q28578744-27DBACCA-EF17-4CF2-8E42-CCE83E4F920DQ33209298-BFF1CB79-B09E-4AFD-B474-B9E3A8186AE9Q34039916-472AC6F6-ED18-47D5-BDEF-3A5059441DDAQ35138860-966D8781-1D31-4A77-A63C-6D90CF46F4D2Q37374789-817AF1BA-FFBC-45CC-A954-467134B57309Q38758120-ED7A93E0-7FFD-49DC-8E8D-493D068C3390Q41724341-F261A2C1-C3D5-4D48-AC57-95F0C20A18C4Q42018514-FE70B9A6-8A49-4C2F-A05D-428FA310EC62Q44174196-430B2A5A-5F0F-44D7-84C1-E898BD61BBA0Q45258258-B30FF391-5A81-4E42-AF6C-06EF9CC75045Q46124032-4DD8B0C5-7572-42D3-B6FF-2BA4113FFAE7Q47408441-1EDF07CD-7524-4A32-9DD8-C181F535B81CQ53644742-2F919686-D465-48DE-BCD9-2AB567964ED8
P2860
Suppression of mesangial proliferative glomerulonephritis development in rats by inhibitors of cAMP phosphodiesterase isozymes types III and IV
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on July 1996
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Suppression of mesangial proli ...... rase isozymes types III and IV
@en
Suppression of mesangial proli ...... ase isozymes types III and IV.
@nl
type
label
Suppression of mesangial proli ...... rase isozymes types III and IV
@en
Suppression of mesangial proli ...... ase isozymes types III and IV.
@nl
prefLabel
Suppression of mesangial proli ...... rase isozymes types III and IV
@en
Suppression of mesangial proli ...... ase isozymes types III and IV.
@nl
P2093
P2860
P356
P1476
Suppression of mesangial proli ...... rase isozymes types III and IV
@en
P2093
H J Walker
J P Grande
R J Johnson
S J Shankland
P2860
P304
P356
10.1172/JCI118788
P407
P577
1996-07-01T00:00:00Z